Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse of Patients with High-Risk MRD-Negative AML after HSCT: An Open-Label, Multicenter, Randomized Controlled Trial

  • Lei Gao
  • , Yanqi Zhang
  • , Sanbin Wang
  • , Peiyan Kong
  • , Yi Su
  • , Jiong Hu
  • , Ming Jiang
  • , Hai Bai
  • , Tao Lang
  • , Jishi Wang
  • , Li Liu
  • , Tonghua Yang
  • , Xiaobing Huang
  • , Fang Liu
  • , Shifeng Lou
  • , Yao Liu
  • , Cheng Zhang
  • , Hong Liu
  • , Li Gao
  • , Jia Liu
  • Lidan Zhu, Qin Wen, Ting Chen, Ping Wang, Jun Rao, Min Mao, Cunbang Wang, Xianlin Duan, Le Luo, Xiangui Peng, Kaniel Cassady, Jiang F. Zhong, Xi Zhang

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)4249-4259
Number of pages11
JournalJournal of Clinical Oncology
Volume38
Issue number36
DOIs
StatePublished - Dec 20 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • Recurrence
  • Prognosis
  • Humans
  • Leukemia, Myeloid, Acute/drug therapy
  • Middle Aged
  • Risk Factors
  • Child, Preschool
  • Male
  • Transplantation Conditioning/methods
  • Antineoplastic Combined Chemotherapy Protocols/pharmacology
  • Young Adult
  • Hematopoietic Stem Cell Transplantation/methods
  • Decitabine/pharmacology
  • Adolescent
  • Antimetabolites, Antineoplastic/pharmacology
  • Adult
  • Female
  • Filgrastim/pharmacology
  • Child

Cite this